Membranous nephropathy in a patient with hereditary angioedema: a case report

<p>Abstract</p> <p>Introduction</p> <p>Hereditary angioedema is the commonest inherited disorder of the complement system and has been associated with several immune glomerular diseases. A case of nephrotic syndrome and renal impairment due to idiopathic membranous glom...

Full description

Bibliographic Details
Main Authors: Majoni Sandawana W, Smith Steven R
Format: Article
Language:English
Published: BMC 2008-10-01
Series:Journal of Medical Case Reports
Online Access:http://www.jmedicalcasereports.com/content/2/1/328
id doaj-8cceabac991e4b51a7ba690604b7b9ff
record_format Article
spelling doaj-8cceabac991e4b51a7ba690604b7b9ff2020-11-24T22:12:50ZengBMCJournal of Medical Case Reports1752-19472008-10-012132810.1186/1752-1947-2-328Membranous nephropathy in a patient with hereditary angioedema: a case reportMajoni Sandawana WSmith Steven R<p>Abstract</p> <p>Introduction</p> <p>Hereditary angioedema is the commonest inherited disorder of the complement system and has been associated with several immune glomerular diseases. A case of nephrotic syndrome and renal impairment due to idiopathic membranous glomerulonephritis in a patient with hereditary angioedema has not been described before.</p> <p>Case presentation</p> <p>We present the first reported case of the association of membranous nephropathy and hereditary angioedema in a 43-year-old male Caucasian patient who presented with acute intestinal angioedema, hypertension, acute pancreatitis, renal impairment and generalised body swelling due to severe nephrotic syndrome. We present the challenges involved in the clinical management of the patient.</p> <p>Conclusion</p> <p>This patient's presentation with severe nephrotic syndrome, renal impairment and hypertension required aggressive treatment of the membranous nephropathy given the high risk for progression to end stage renal failure. The contraindication to angiotensin converting enzyme inhibitors and angiotensin II receptor blockers in this patient, the lack of published evidence on the use of alkylating agents and other immunosuppressive agents in patients with hereditary angioedema and the lack of published data on the management of similar cases presented a clinical challenge in this patient's management.</p> http://www.jmedicalcasereports.com/content/2/1/328
collection DOAJ
language English
format Article
sources DOAJ
author Majoni Sandawana W
Smith Steven R
spellingShingle Majoni Sandawana W
Smith Steven R
Membranous nephropathy in a patient with hereditary angioedema: a case report
Journal of Medical Case Reports
author_facet Majoni Sandawana W
Smith Steven R
author_sort Majoni Sandawana W
title Membranous nephropathy in a patient with hereditary angioedema: a case report
title_short Membranous nephropathy in a patient with hereditary angioedema: a case report
title_full Membranous nephropathy in a patient with hereditary angioedema: a case report
title_fullStr Membranous nephropathy in a patient with hereditary angioedema: a case report
title_full_unstemmed Membranous nephropathy in a patient with hereditary angioedema: a case report
title_sort membranous nephropathy in a patient with hereditary angioedema: a case report
publisher BMC
series Journal of Medical Case Reports
issn 1752-1947
publishDate 2008-10-01
description <p>Abstract</p> <p>Introduction</p> <p>Hereditary angioedema is the commonest inherited disorder of the complement system and has been associated with several immune glomerular diseases. A case of nephrotic syndrome and renal impairment due to idiopathic membranous glomerulonephritis in a patient with hereditary angioedema has not been described before.</p> <p>Case presentation</p> <p>We present the first reported case of the association of membranous nephropathy and hereditary angioedema in a 43-year-old male Caucasian patient who presented with acute intestinal angioedema, hypertension, acute pancreatitis, renal impairment and generalised body swelling due to severe nephrotic syndrome. We present the challenges involved in the clinical management of the patient.</p> <p>Conclusion</p> <p>This patient's presentation with severe nephrotic syndrome, renal impairment and hypertension required aggressive treatment of the membranous nephropathy given the high risk for progression to end stage renal failure. The contraindication to angiotensin converting enzyme inhibitors and angiotensin II receptor blockers in this patient, the lack of published evidence on the use of alkylating agents and other immunosuppressive agents in patients with hereditary angioedema and the lack of published data on the management of similar cases presented a clinical challenge in this patient's management.</p>
url http://www.jmedicalcasereports.com/content/2/1/328
work_keys_str_mv AT majonisandawanaw membranousnephropathyinapatientwithhereditaryangioedemaacasereport
AT smithstevenr membranousnephropathyinapatientwithhereditaryangioedemaacasereport
_version_ 1725802236884287488